Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates Life Science Investing
Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update Pharmaceutical Investing
argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada Biotech Investing
MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development Life Science Investing
Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations Technology Investing
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 Life Science Investing
Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update Life Science Investing
PainReform's DeepSolar, Developing "DeepSolar Predict" within the NVIDIA Connect Program, Featured in The Market Link's "Watchlist Interview" and Announces Progress Toward Pilot Projects Life Science Investing
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results Life Science Investing
